The role of genetic testing within maternal medicine is expanding. Advancing technology and the increasing availability of genetic testing have seen more patients receiving a genetic diagnosis than ever before. Improved healthcare and understanding of these rare diseases means that many patients are living well into their reproductive years and starting families.
View Article and Find Full Text PDFBackground: Recurrent miscarriage affects 1-2% of the population, and the literature has focussed on causes, treatment, and live birth rate.
Aim: This study aimed to assess the reproductive outcomes for patients who attended a specialist recurrent miscarriage clinic for investigation and treatment.
Methods: Prospective analysis of all patients who attended a recurrent miscarriage clinic from January 2014 to January 2021.
Background: Second-trimester loss is pregnancy loss after the 12th and before the 24th completed weeks of pregnancy. This study aims to review cases of second-trimester miscarriage who attended a large maternity hospital and to examine pregnancy outcomes in this group of women.
Methods: This study is a review of cases of second-trimester miscarriage using descriptive, exploratory design, involving a retrospective chart review.